Tuesday, June 26, 2012

Alzheimer's Clips News 104


Frightened, Bewildered, Apprehensive, Anxious, Angry

Don't get angry at the actions of someone that is deeply forgetful. Instead start asking yourself why are they reacting this way? How are they feeling (them, not you)?

Bored, frightened, bewildered, apprehensive, anxious and angry. I can say that everyone of those words applied to Dotty when I first arrived in Delray Beach to care for her. 
  
It just amazed me how easy it was for her to get out of balance. To get mean. 
  
How simple? Consider this. Dotty would be standing there with the door wide open on the refrigerator and making a sandwich. She didn't do it the way most of us do it. We usually take all of the component parts out of the refrigerator, close the door, put every thing on the counter, then make the sandwich.  
  
In our home when you keep the door on our refrigerator open too long, or if the door is ajar, the refrigerator starts beeping. It has an alarm system to alert you that the door is not properly closed. 
  
You ever hear a refrigerator beep for like five minutes? Let me tell you, after 15 seconds it will drive you nuts. You might likely overreact. I did. 


Dotty's Last Meal, Can you guess what she ate?

As I am sitting here it just dawned on me that Dotty had one of her favorites for her last full meal.

I seem to be waking up. I am thinking more about Dotty every day. All good by the way. 
  
I am also up to two dreams. Very interesting. One had an amazing looking tornado trying to form in it, and I was going about the business of protecting Dotty, and getting her into a safe place. There was no fear or angst on my part, and Dotty seemed relatively calm. I need the
Jungians to interpret this one. 
  
As I was sitting here it just dawned on me that Dotty had one of her favorites for her last full meal. 
  
Can you guess before you look?    


A Molecule Designed with High Potential in Future Treatments for Alzheimer's disease

ASS234 was developed as a hybrid of two known molecules.

Researchers at Universitat Autònoma de Barcelona (UAB), the Spanish National Research Council (CSIC) and the University of Barcelona (UB) have developed a multitarget molecule, ASS234, which according to the results of in vitro studies conducted, inhibits the aggregation of the ß-amyloid protein, involved in Alzheimer's disease.
  
In vitro studies reveal a reduction in the ß-amyloid peptide aggregation, involved in the disease, and a boost in cognitive function. 
  
It could lead the development of more efficient drugs than those currently used.